HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hua Lu Selected Research

Bortezomib (Velcade)

1/2014In vitro migratory aberrancies of mesenchymal stem cells derived from multiple myeloma patients only partially modulated by bortezomib.
10/2011[Effect of proteasome inhibitor on migration ability and hepatocyte growth factor expression of bone marrow mesenchymal stem cells in multiple myeloma patients].
12/2010[Therapeutic efficacy of bortezomib-based chemotherapy on 40 patients with multiple myeloma].
4/2009Bortezomib in combination with dexamethasone for a young multiple myeloma with t(8; 14).
1/2009BAG3 gene silencing sensitizes leukemic cells to Bortezomib-induced apoptosis.
10/2008[Effects of proteasome inhibitor bortezomib on NF-kappaB activity and ICAM-1 mRNA expression of K562 cells].
8/2008[Clinical study of bortezomib in combination with dexamethasone for the treatment of multiple myeloma].
2/2006[Effects of proteasome inhibitor PS-341 on the multiple cytokine expressions of mesenchymal stem cells from bone marrow in patients with multiple myeloma].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hua Lu Research Topics

Disease

76Neoplasms (Cancer)
05/2022 - 06/2002
14Multiple Myeloma
12/2022 - 02/2006
11Infections
03/2021 - 12/2005
10Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2015 - 10/2007
9Leukemia
12/2021 - 04/2003
7Carcinogenesis
01/2020 - 03/2006
7Disease Resistance
01/2018 - 10/2004
5Neoplasm Metastasis (Metastasis)
10/2021 - 01/2016
5Hemorrhage
03/2021 - 01/2015
5Inflammation (Inflammations)
09/2020 - 08/2010
4Infertility (Sterility)
01/2021 - 01/2014
4Hepatocellular Carcinoma (Hepatoma)
01/2020 - 01/2017
4Prostatic Neoplasms (Prostate Cancer)
01/2020 - 11/2013
4Hematologic Neoplasms (Hematological Malignancy)
01/2016 - 04/2006
3Ovarian Neoplasms (Ovarian Cancer)
05/2022 - 08/2016
3Chronic Obstructive Pulmonary Disease (COPD)
01/2022 - 02/2018
3Breast Neoplasms (Breast Cancer)
01/2021 - 06/2005
3Lymphoma (Lymphomas)
01/2021 - 04/2003
3Acute Promyelocytic Leukemia
01/2021 - 05/2009
3Colonic Neoplasms (Colon Cancer)
11/2020 - 06/2002
3Fibrosis (Cirrhosis)
09/2020 - 01/2017
3Obesity
07/2020 - 01/2015
3Thrombosis (Thrombus)
04/2020 - 02/2015
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
04/2018 - 08/2006
3Hematologic Diseases (Blood Diseases)
07/2016 - 12/2008
3Atrophy
11/2013 - 01/2011
3Chromosome Aberrations (Chromosome Abnormalities)
09/2012 - 10/2006
2Carcinoma (Carcinomatosis)
05/2022 - 10/2002
2Heart Arrest (Cardiac Arrest)
04/2022 - 08/2016
2Acute Kidney Injury (Acute Renal Failure)
01/2022 - 04/2018
2Chronic Renal Insufficiency
01/2022 - 07/2020
2Traumatic Brain Injuries (Traumatic Brain Injury)
11/2021 - 01/2020
2Parkinson Disease (Parkinson's Disease)
11/2021 - 01/2013
2Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 09/2018
2Aneurysm (Aneurysms)
01/2021 - 12/2012
2Glioma (Gliomas)
12/2020 - 10/2020
2Ischemia
09/2020 - 04/2010
2Intervertebral Disc Displacement (Herniated Disc)
08/2020 - 01/2013

Drug/Important Bio-Agent (IBA)

32Proteins (Proteins, Gene)FDA Link
05/2022 - 01/2003
11Pharmaceutical PreparationsIBA
01/2021 - 03/2007
8Granulocyte Colony-Stimulating Factor (G-CSF)IBA
03/2015 - 04/2003
8Bortezomib (Velcade)FDA Link
01/2014 - 02/2006
7MicroRNAs (MicroRNA)IBA
06/2020 - 01/2010
6Cytarabine (Cytosar-U)FDA LinkGeneric
03/2015 - 10/2007
6inauzhinIBA
01/2015 - 01/2012
6Messenger RNA (mRNA)IBA
01/2015 - 04/2003
6Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric
06/2013 - 02/2004
5CytokinesIBA
01/2020 - 02/2006
4Long Noncoding RNAIBA
12/2021 - 10/2017
4DNA (Deoxyribonucleic Acid)IBA
01/2020 - 06/2002
4Sirtuin 1IBA
01/2019 - 01/2012
4Oncogene Proteins (Oncogene Protein)IBA
03/2012 - 08/2006
3Biological ProductsIBA
05/2022 - 04/2003
3ElementsIBA
01/2022 - 02/2017
3Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2021 - 06/2002
3Transcription Factors (Transcription Factor)IBA
01/2021 - 05/2009
3LigandsIBA
01/2021 - 12/2017
3NF-kappa B (NF-kB)IBA
11/2020 - 10/2008
3Peptides (Polypeptides)IBA
10/2020 - 07/2011
3Superoxide DismutaseIBA
09/2020 - 08/2010
3Malondialdehyde (Propanedial)IBA
09/2020 - 04/2010
3Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA
01/2020 - 10/2016
3Aflatoxin B1 (Aflatoxin B)IBA
01/2020 - 12/2017
3Indicators and Reagents (Reagents)IBA
08/2019 - 11/2013
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2019 - 06/2005
3Fluorouracil (Carac)FDA LinkGeneric
09/2018 - 03/2007
3InterferonsIBA
01/2018 - 03/2006
3Ribosomal Proteins (Ribosomal Protein)IBA
10/2017 - 10/2008
3Therapeutic UsesIBA
05/2015 - 05/2009
3AclarubicinIBA
03/2015 - 10/2007
3you-gui-wanIBA
01/2015 - 11/2013
3Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
06/2014 - 01/2009
3Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
05/2014 - 03/2009
3Proteasome InhibitorsIBA
10/2011 - 02/2006
3SeleniumIBA
06/2006 - 01/2006
2UbiquitinIBA
05/2022 - 01/2019
2Ligases (Synthetase)IBA
05/2022 - 01/2019
2Lidocaine (Xylocaine)FDA LinkGeneric
04/2022 - 06/2021
2Singlet OxygenIBA
01/2022 - 01/2019
2Biomarkers (Surrogate Marker)IBA
01/2022 - 12/2016
2Photosensitizing Agents (Photosensitizers)IBA
01/2022 - 01/2019
2MicellesIBA
01/2022 - 05/2017
2Poly(ADP-ribose) Polymerase InhibitorsIBA
12/2021 - 01/2021
2AntibodiesIBA
01/2021 - 01/2018
2histone deacetylase 3IBA
12/2020 - 10/2020
2RGFP966IBA
12/2020 - 10/2020
2CeramidesIBA
11/2020 - 01/2017
2icariinIBA
11/2020 - 03/2020
2InterleukinsIBA
09/2020 - 01/2015
2VancomycinFDA LinkGeneric
08/2020 - 06/2017

Therapy/Procedure

34Therapeutics
12/2022 - 10/2008
11Drug Therapy (Chemotherapy)
04/2021 - 06/2008
6Transplantation
12/2021 - 01/2002
4Hematopoietic Stem Cell Transplantation
01/2022 - 04/2014
3Lasers (Laser)
01/2022 - 05/2008
3Stents
01/2021 - 12/2013
3Length of Stay
12/2019 - 04/2017
3Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
04/2013 - 10/2008
2Renal Dialysis (Hemodialysis)
01/2022 - 11/2011
2Artificial Respiration (Mechanical Ventilation)
07/2020 - 02/2019